This Colorectal Cancer Awareness Month, we’re highlighting the work of Gates Institute research member Chris Lieu, MD—an innovator whose impact spans CU Anschutz and far beyond. A leader in gastrointestinal oncology, his research targets some of the field’s most urgent challenges, from early-onset cancers to treatment resistance, while advancing promising therapies into first-in-human clinical trials. In his roles across the CU Anschutz Division of Medical Oncology, the CU Anschutz Cancer Center, and GI Medical Oncology, he brings vision and collaboration to every effort. When the Dudley Solid Tumor Cellular Therapy Fund was formed, creating a partnership between Gates Institute and CU Anschutz Cancer Center, he was a natural fit to lead research that aims to drive the development of a first-in-class cellular therapy for colorectal cancer, pushing the boundaries of what’s possible in cancer treatment.